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A point mutation in AgrC determines 
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associated with phenotypic 
variants of ST22 MRSA strains
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Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of skin and soft tissue infections. 
One of the highly successful and rapidly disseminating clones is MRSA ST22 commonly associated 
with skin tropism. Here we show that a naturally occurring single amino acid substitution (tyrosine to 
cysteine) at position 223 of AgrC determines starkly different ST22 S. aureus virulence phenotypes, 
e.g. cytotoxic or colonizing, as evident in both in vitro and in vivo skin infections. Y223C amino acid 
substitution destabilizes AgrC-AgrA interaction leading to a colonizing phenotype characterized by 
upregulation of bacterial surface proteins. The colonizing phenotype strains cause less severe skin 
tissue damage, show decreased susceptibility towards the antimicrobial LL-37 and induce autophagy. 
In contrast, cytotoxic strains with tyrosine at position 223 of AgrC cause infections characterized by 
inflammasome activation and severe skin tissue pathology. Taken together, the study demonstrates 
how a single amino acid substitution in the histidine kinase receptor AgrC of ST22 strains determines 
virulence properties and infection outcome.
Staphylococcus aureus has long been recognized as a major human pathogen causing both hospital-associated and 
community-acquired (CA) infections. The health burden associated with these infections is further heightened by 
the emergence of methicillin-resistant S. aureus (MRSA) worldwide1–4. Epidemiologic studies from the US have 
identified MRSA as the major cause of skin and soft tissue infections5,6. In addition, Klevens et al.2 reported that 
MRSA causes more deaths in the US than any other infectious disease including HIV/AIDS.
The spread of MRSA worldwide is due to the dissemination of a limited number of MRSA clones (reviewed 
in7). Epidemic MRSA-15 (EMRSA-15), belonging to the multilocus sequence type (ST) ST22 is recognized as a 
particularly successful, rapidly disseminating clone that has spread across continents8,9. In the UK, EMRSA-15 
emerged in the early 1990s and 10 years later, it accounted for 60% of all MRSA nosocomial bacteremia cases10. In 
a recent study comparing S. aureus bloodstream infections from 2011 with 2006 data, ST22 was identified as the 
most markedly expanding MRSA clone in Europe11. Taken together with reports of Panton-Valentine Leukocidin 
(PVL)-positive ST22 strains associated with outbreaks of neonatal infections12 as well as skin and soft tissue infec-
tions13–15, the rapid expansion of these ST22 strains is a concerning development.
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S. aureus expresses a wide array of virulence factors, including among others secreted toxins that are strongly 
implicated in the pathogenic mechanisms underlying toxic shock, severe pneumonia and complicated skin and 
soft tissue infections16,17. These include superantigens (staphylococcal enterotoxins and TSST-1), and cyto-
toxins such as PVL, α -toxin, and the phenol soluble modulins (PSM)16–18. Apart from that S. aureus can also 
express a broad range of cell surface virulence factors that are covalently attached to peptidoglycan, known as 
cell wall-anchored proteins19. These surface proteins play a major role in promoting the bacterial adhesion and 
invasion of extracellular matrix and host cells, and are critical in determining the success of the bacterium as a 
colonizer, persister and/or pathogen19,20. A key regulator of virulence factor expression is the accessory gene reg-
ulator (agr) quorum-sensing system composed of AgrA (response regulator), B (integral membrane protease), 
C (histidine kinase), and D (auto-inducing peptide)21. Clinical isolates exhibiting agr-defective phenotypes have 
been reported, with dysfunction being beneficial for survival and persistence within the infected host but counter 
selected for against transmission22–25. Also, recent studies have emphasized the impact of differential expression 
of the toxins on the strains’ virulence properties26,27.
In our previous study, we identified two ST22 MRSA strains with the same genetic background (ST22, agrI, 
PVL+ , mecA+ , identical virulence gene profile) that displayed starkly different phenotypic response profiles, i.e. 
either proliferative or cytotoxic responses26. In this report, whole genome sequencing was applied to these clinical 
ST22 variants. The analyses identified a specific mutation in agrC, which contributed to differential virulence 
profiles in in vitro cell and tissue model systems, as well as in vivo in a murine tissue infection model. We show 
that this specific AgrC variation determines cytotoxic or colonizing infection profiles in infected tissue.
Results
Distinct phenotypic virulence profiles of ST22 strains associated with a naturally occurring sin-
gle point mutation in agrC. In the report by Mairpady Shambat et al.26, different phenotypic response 
profiles were noted in peripheral blood mononuclear cells (PBMC) exposed to varying S. aureus strains from 
different genetic backgrounds and even within the same ST type such as ST22 (Supplementary Table 1). Here we 
focused on two ST22 MRSA skin isolates, specifically: M37 isolated from recurrent skin infection and PUNE08 
isolated from an acute soft tissue infection. The strains had identical virulence gene profiles as determined by 
DNA microarray28 (Supplementary Table 2), and yet displayed starkly different phenotype profiles (cytotoxic 
versus proliferative).
First, we compared their phenotypic profile with two EMRSA-15 reference strains, HAR22 and NCTC13142. 
PBMC from three donors were stimulated with serial dilutions of bacterial overnight culture supernatants and 
proliferative activity was determined. Supernatant from strain M37 induced proliferation at all dilutions tested, 
whereas PUNE08 and the reference strains induced proliferation only at the highest dilution (1:1000) (Fig. 1a). 
To test whether the lack of proliferation in more concentrated supernatants was due to cytotoxicity, prolifera-
tion was assessed following stimulations of PBMC with PHA in combination with bacterial supernatants. The 
PHA-response was augmented by the supernatant from the proliferative strain M37, while completely abolished 
by supernatants at 1:50 dilutions from the other strains (Fig. 1a), indicating a cytotoxic effect towards PBMC. 
This was also reflected in the LDH-cytotoxicity assay, where PUNE08 induced significantly higher cytotoxicity in 
human PBMC, neutrophils (PMN) and keratinocytes (N/TERT-1 cells) (Fig. 1b). This was in line with increased 
toxin levels in supernatants from PUNE08 as compared to M37 (Supplementary Table 1). The higher toxin pro-
duction was also evident as judged by the larger hemolysis zones around PUNE08 colonies on sheep blood agar as 
compared to M37 (Fig. 1c and Supplementary Fig. 1e). The two reference strains showed hemolysis and cytotoxic 
patterns resembling that of PUNE08, i.e. larger hemolysis zones and greater cytotoxicity as compared to M37 
(Fig. 1a–c).
To identify the genetic factor responsible for this phenotypic diversity the whole genome of PUNE08 and M37 
was determined (sequences are deposited in DNA data bank of Japan (DDBJ) and the accession numbers are M37: 
BCLL01000001-BCLL01000060 and PUNE08: BCLM01000001-BCLM01000056). Sequence analyses revealed a 
single nucleotide mutation at position 667 of the agrC gene in strain M37 compared to PUNE08 leading to an 
amino acid substitution from tyrosine (Y) to cysteine (C) at position 223 (Fig. 1d). Of note, sequence comparisons 
of other virulence factors and regulators, including regions of the agr loci, were analyzed but did not reveal any 
additional polymorphism or inactivating mutations. agrC gene specific amplification and sequencing of the two 
European reference strains (HAR22 and NCTC13142) showed that they had the same allele (Y223) as PUNE08 
(Fig. 1d). Furthermore, agrC sequence analyses of a panel of ST22 MRSA clinical isolates (Supplementary Table 1) 
revealed that the two proliferative strains, including M37, both had cysteine in position 223 whereas the other 
strains that were all cytotoxic had tyrosine in this position (Supplementary Fig. 1a).
A molecular model of AgrC protein with Y223C amino acid substitution showed that mutation lies at the 
dimerization interface of the cytosolic domain of AgrC (Fig. 1e). Solution properties of the purified, recombinant 
AgrCY223C protein were examined by size exclusion chromatography and Dynamic Light Scattering. Although the 
protein was readily purified to homogeneity, it was highly prone to aggregation. This observation is consistent 
with the size exclusion chromatography profile as well as Dynamic Light Scattering (Supplementary Fig. 1a–d). 
While the cytosolic domain of the wild-type AgrC is monodispersed, AgrCY223C is predominantly aggregated in 
solution. We also note a marked reduction, up to ten fold, in binding affinity of the AgrCY223C protein with AgrA 
as compare to the wild-type AgrC (Fig. 1f,g).
Amino acid substitution in AgrC results in a phenotypic switch. Through allelic replacement we 
generated agrC mutant strains (Y223C and C223Y) in PUNE08 and M37 genetic backgrounds, respectively 
(Fig. 2a). The substitution of amino acids was directly associated with toxin production, as assessed by hemol-
ysis on blood agar (Fig. 2b and Supplementary Fig. 1e). In contrast to their respective wild-type strain (wt), the 
PUNE08 agrC-Y223C mutant showed no hemolysis, whereas the M37 agrC-C223Y mutant had a clear hemolysis 
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around the colonies. A similar distinct phenotypic switch was evident when culture supernatants from the strains 
were tested in proliferation and cytotoxicity assays (Fig. 2c,d). M37 wt switched from a proliferative to a cytotoxic 
profile in the agrC mutant, whereas the opposite was noted for PUNE08 wt and its mutant. Taken together, the 
results demonstrate that the cytotoxic activity is dependent on tyrosine at position 223 of AgrC.
To test the impact of the agrC mutation on virulence gene expression, a panel of genes encoding exotoxins and 
cell surface proteins was analyzed in stationary phase bacterial cultures. Consistent with the noted cytotoxicity, 
strains harboring the tyrosine at position 223 of AgrC showed a higher abundance of RNAIII, as well as exotoxin 
transcripts e.g. hla, psmα, and lukSPV (Fig. 3a). In contrast, strains with the agrC-Y223C variant expressed higher 
transcript levels of cell surface proteins (e.g. spa, clfA, clfB, and fnbA) and lower RNAIII and exotoxin transcripts 
(Fig. 3b); thus, indicating a colonizing phenotype. In line with this assumption, live infections with M37 wt 
and PUNE08 agrC-Y223C showed significantly higher adherence to and internalization into keratinocytes than 
PUNE08 wt and M37 agrC-C223Y (Fig. 3c,d). Similar to previous data using bacterial supernatants, live infection 
with PUNE08 wt and M37 agrC-C223Y triggered significantly higher cytotoxicity (Fig. 3e). As staphylococcal 
protein A (SPA) has been reported to interact with and upregulate TNF-R129,30, and the toxin mediated cyto-
toxicity has been linked to inflammasome/caspase-1 activation31,32, these were selected as markers for a differ-
ential host response. In agreement with bacterial gene expression data, keratinocytes infected with M37 wt and 
PUNE08 agrC-Y223C (i.e. strains with upregulated spa) showed increased amounts of TNF-R1 levels, whereas 
PUNE08 and M37 agrC-C223Y (i.e. strains with upregulated toxin genes) showed augmented pro-caspase 1 
(α and β ) and active p20 subunit levels (Fig. 3f and Supplementary Fig. 2). In addition, activation of caspase 1 was 
Figure 1. Natural amino acid sequence variation in AgrC results in different phenotypic profiles of clinical 
S. aureus strains. (a) Proliferative or cytotoxic responses by human peripheral blood mononuclear cells (PBMC) 
isolated from three healthy donors stimulated with indicated dilution series of bacterial supernatants prepared 
from overnight cultures of S. aureus strains. Stimulation without (left panel) and with (right panel) addition of 
PHA to each supernatant are shown. The data represent the mean values ± s.d. (n  =  3). (b) Cytotoxicity induced 
by bacterial supernatants of 1:50 dilutions towards PBMC, human neutrophils (PMN) and human keratinocytes 
(N/TERT-1). Mean values ± s.d. from four or more volunteers (PBMC, PMN) or experiments are shown (n ≥ 4). 
The statistical significance between PUNE08 and M37 strains was determined using two-tailed Mann-Whitney 
U-test (* p < 0.05). (c) Representative images of hemolysis on blood agar plates induced by indicated clinical 
S. aureus strains (see also Supplementary Fig. 1e). (d) Amino acid sequence analysis of AgrC from indicated 
strains at specified positions. (e) Theoretical side and front representation of AgrCY223C protein dimeric structure 
showing two cysteines at 223rd position which are placed ~15 Å apart. (f) Quantification of the interaction of 
recombinant wild-type AgrC (upper panel) and AgrCY223C (lower panel) (analytes) with immobilized AgrA 
(ligand) using bio-layer interferometry. (Note the difference in scale between upper panel and lower panel). 
Representative profiles of the relative bio-layer Interferometry responses for the association and dissociation 
of different analyte concentrations in combination with DTT and H2O2 are shown (n = 2). (g) The values for 
dissociation constant (Kd) were calculated from the binding data with the Octet Data Analysis Software v 8.0.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:31360 | DOI: 10.1038/srep31360
measured using fluorescent probe carboxyfluorescein (FMK)-YVAD-fluoromethyl ketone (FMK). The percent-
age of FAM-YVAD-FMK positive cells was significantly higher in PUNE08 wt and M37 agrC-C223Y infected 
cultures (Fig. 3g,h and Supplementary Fig. 3). Based on these findings we postulate that (i) strains harboring 
tyrosine in position 223 of AgrC are more cytotoxic in nature, whereas (ii) strains harboring the cysteine in this 
position have characteristics of a colonizing phenotype.
Cytotoxic strains harboring tyrosine in position 223 of AgrC cause more severe tissue damage 
in a human 3D skin model. To test this hypothesis, human organotypic skin tissue with a stratified epithe-
lium and a dermal fibroblast layer was infected with the different strains. All six strains readily infected the skin 
tissue and equal bacterial load was detected 24 h post infection (Fig. 4a). Histological analyses of hematoxylin/
eosin stained tissue revealed that all cytotoxic strains elicited more severe tissue damage characterized by epithe-
lial disruption and detachment as compared to the less cytotoxic strains (Fig. 4b). Gene expression analyses of the 
infected skin tissue model (Fig. 4c,d) revealed a similar differential virulence gene expression profile as noted in 
stationary phase bacterial cultures (Fig. 3a,b). In addition, IL-1β , TNF, CXCL8 and IL-6 were assessed at mRNA 
and protein levels in infected skin models. This revealed that the cytotoxic PUNE08 wt and M37 agrC-C223Y 
strains induced higher IL-1β , CXCL8, and IL-6 as compared to the colonizing M37 wt and PUNE08 agrC-Y223C 
(Fig. 4e–h), whereas the reverse was true for TNF (Fig. 4f). Thus the data are in agreement with the noted acti-
vated caspase-1 versus upregulated TNF-R1 expression in infected keratinocytes.
Figure 2. Phenotypic switch of the PUNE08 and M37 S. aureus strains due to direct substitution of tyrosine 
to cysteine or cysteine to tyrosine at the position 223 in AgrC. (a) Amino acid sequence analysis of AgrC 
from indicated wild-type and respective mutant strains. (b) Representative images of hemolysis on blood 
agar plates induced by indicated wild-type and respective mutant S. aureus strains (see also Supplementary 
Fig. 1e). (c) Proliferative or cytotoxic responses by human PBMC isolated from three healthy donors stimulated 
with indicated dilution series of bacterial supernatants. Stimulation without (left panel) and with (right 
panel) addition of PHA to each supernatant are shown. The data represent the mean values ± s.d. (n  =  3). (d) 
Cytotoxicity induced by bacterial supernatants of 1:50 dilutions towards human PBMC, human neutrophils 
(PMN) and human keratinocytes (N/TERT-1). Mean values ± s.d. from four or more volunteers (PBMC, PMN) 
or experiments are shown (n ≥ 4). The statistical significance between wild-type and respective mutant strains 
was determined using two-tailed Mann-Whitney U-test (* p < 0.05; * * p < 0.01; * * * p < 0.001).
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Colonizing strains harboring cysteine in position 223 of AgrC show a persistence phenotype in a 
human 3D skin model. To further investigate the noted difference in adherence and internalization between 
the strains, imaging studies were performed in infected keratinocytes and organotypic skin tissue. We focused on 
LAMP-1 and autophagy as both of these have been implicated in intracellular persistence24,33. Confocal analyses 
revealed that M37 wt and PUNE08 agrC-Y223C strains strongly co-localized with both LAMP1 as well as with 
the autophagosome marker LC3 (Fig. 5a–j, Supplementary Figs 4–7). In contrast, only minor co-localization with 
LAMP1 or LC3 was observed in cells or tissue infected with the cytotoxic PUNE08 wt and M37 agrC-C223Y 
strains. In addition, a strong induction of autophagy was seen exclusively for M37 wt and PUNE08 agrC-Y223C 
strains (Fig. 5e–j, Supplementary Figs 6 and 7).
Another common property associated with colonization and persistence is resistance against antibiotics and 
antimicrobials, such as the LL-37 which is abundantly expressed in skin34–37. Determination of minimum inhib-
itory concentrations (MIC) of LL-37 revealed that the M37 wt and PUNE08 agrC-Y223C strains were less sus-
ceptible to LL-37 than PUNE08 wt and M37 agrC-C223Y (Fig. 5k). Taken together, the data support an enhanced 
Figure 3. Differential gene expression and virulence profile in strains with different AgrC variants.  
(a) Relative mRNA expression of indicated genes regulating or encoding exotoxins from stationary phase 
bacterial cultures. The data represent the mean values ± s.d. from three independent experiments (n = 3). (b) 
Relative mRNA expression of indicated genes encoding for surface-attached proteins from stationary phase 
bacterial cultures. The data represent the mean values ± s.d. from three independent experiments (n = 3). (c) 
Bacterial adherence to, internalization into (d) and cytotoxicity towards (e) human keratinocytes after two hours 
of infection. The data represent the mean values ± s.d. (n ≥ 4). The statistical significance between wild-type and 
respective mutant strains was determined using two-tailed Mann-Whitney U-test (* * p < 0.01). (f) Representative 
images of Western Blot analyses of TNF-R1 and Caspase 1 subunits expression after 2 and 4 h of keratinocytes 
infection. β -actin was used as a loading control (n = 4). Uncropped full-size blots are shown in supplementary 
Fig. 2. (g) Representative images of caspase 1 activation after 2 h of keratinocytes monolayer infection with 
indicated strains (n = 3). (h) Quantitative analysis of caspase 1 positive cells after 2 h of infection. Number of 
cells were calculated in multiple fields (n = 5). The data represent the mean values ± s.d. from three independent 
infections (n = 3). The statistical significance between wild-type and respective mutant strains was determined 
using two-tailed Mann-Whitney U-test (* * * p < 0.001).
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Figure 4. AgrC variation determines the severity of infection in skin tissue model. (a) Total CFU counts of bacteria 
recovered from skin tissue models after 24 h of infection with indicated S. aureus strains. The data represent the mean 
values ± s.d. (n ≥ 3). (b) Histological analysis of the skin tissue models after infection. Representative images 24 h post 
infection and blinded scoring analysis with indicated strains are shown (n ≥ 3). Horizontal lines denote median values. 
The statistical significance between wild-type and respective mutant strains was determined using two-tailed Mann-
Whitney U-test (* p < 0.05). (c) Relative mRNA expression of indicated genes regulating or encoding exotoxins during 
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colonizing/persistent phenotype of M37 wt and PUNE08 agrC-Y223C strains, associated with an enhanced 
exploitation of autophagy and decreased susceptibility to LL-37.
Phenotypic AgrC variants cause varying disease severity in vivo. To verify the in vitro findings in an 
in vivo skin infection model, three mouse lines of different genetic backgrounds (C57BL/6J, DBA/2J, and BALB/c) 
were infected subcutaneously with PUNE08 wt, M37 wt, and their respective mutant strains. All mice survived 
a six days infection period. After euthanization the CFU numbers derived from skin, spleen, and kidney were 
analyzed. This revealed no significant differences between the bacterial strains in terms of skin colonization or 
systemic spread (Fig. 6a). However, comparison of lesion sizes six days post infection revealed significantly larger 
lesions induced by the cytotoxic strains PUNE08 wt and M37 agrC-C223Y as compared to M37 wt and PUNE08 
agrC-Y223C in all mice analyzed (Fig. 6b,c).
Discussion
In this study we characterize two clinical ST22 MRSA strains associated with skin and soft tissue infections dis-
playing starkly different phenotypic response profiles despite having identical virulence gene profiles. We identify 
that a single amino acid substitution in the AgrC (tyrosine to cysteine at position 223) leads to a destabilization 
of the AgrC-AgrA interaction with a subsequent differential regulation of the virulence gene repertoire resulting 
in a switch from a cytotoxic, toxin-mediated phenotype to a colonizing phenotype. The cytotoxic variant was 
isolated from a patient with acute soft tissue infection, while the colonizing variant from a patient with repeated 
recurrent skin infections.
The Agr is a key regulatory system of virulence gene expression in S. aureus and both agrC and agrA regions 
are hot spots for single point mutations22. Phosphorylation of AgrA by AgrC triggers the expression profile in 
response to a quorum stimulus38. Phosphorylated AgrA is a dimer in solution and preferentially induces the 
expression of phenol soluble modulins (PSMs)39 as well as that of RNAIII, the effector RNA that governs the 
expression of multiple genes. Typically a high RNAIII will result in a reduced expression of cell surface proteins 
while increased expression of exotoxin genes39. Of note, a G55R substitution in AgrC has been observed among 
most contemporary CC30 isolates25, and a L184I substitution has been identified in the derived clade of the 
community-acquired MRSA ST80 lineage40. However the point mutation at position 223 of AgrC identified and 
characterized in this report has to our knowledge not been reported previously. AgrC with tyrosine at position 
223 was the most common variant being identified in 8 out of the 10 ST22 strains analyzed including the two 
EMRSA-15 reference strains. We demonstrate through structural and biophysical studies that the Y223C sub-
stitution affects the oligomeric assembly of AgrC due to aggregation in solution. The poor interaction between 
the aggregated AgrCY223C protein and response regulator AgrA is likely to contribute to the noted differential 
gene expression. Our data demonstrate that tyrosine at position 223 of AgrC plays an important role in high 
toxin expression profile of ST22 MRSA resulting in increased cytotoxicity against varying cell types and more 
severe tissue damage both in vitro and in vivo. In contrast, strains harboring cysteine at position 223 of AgrC 
have upregulated genes encoding for cell surface proteins resulting in increased adherence and internalization by 
keratinocytes; characteristics of a colonizing/persistent phenotype41–43. One of the upregulated genes was spa, and 
consistent with the known interaction of SPA with TNF-R1, TNF was more abundant at the mRNA and protein 
level in tissue models infected with strains exhibiting colonizing phenotype.
Furthermore, our data demonstrate that colonizing and cytotoxic strains differed with respect to intracellular 
locality as the colonizing strains showed a greater co-localization with LAMP1 as well as with LC3-positive auto-
phagic compartments; features usually associated with more persistent strains. There was also a marked induction 
of autophagy by the colonizing, but not cytotoxic, strains. In addition, reduced caspase 1 and IL1-β levels were 
noted in cells and tissue infected with strains having a colonizing phenotype, while both were strongly induced 
following infection with the cytotoxic strains. This variation is consistent with the link between autophagy and 
consumption of inflammasome components24,44,45. Considering that inflammasome activation has been reported 
as a mechanism of S. aureus clearance31,32,46, our data would imply that this protective host response is less pro-
nounced in infections with strains having a colonizing/persistent phenotype as compared to a cytotoxic phe-
notype. In addition, the colonizing phenotype was also linked to a decreased susceptibility to the antimicrobial 
peptide LL-37. This peptide has been ascribed a critical role in the immune defense mechanisms in bacterial 
infections in the skin36,37. The exact mechanism of resistance towards LL-37 warrants further studies.
Overall our data from ST22 S. aureus strains show that natural AgrC variants with starkly different phenotypes 
exist among clinical strains. The colinizing/persistent phenotype was identified in a recurrent skin infection case, 
while the cytotoxic phenotype was recovered from a patient with an acute soft tissue infection. The cytotoxic phe-
notype elicited severe tissue pathology both in a human skin tissue model as well as in an in vivo murine model. 
The murine model revealed significantly larger tissue lesions with the cytotoxic as compared to the colonizing/per-
sistent strains. In other reports, single point mutations in the agr locus or the hla gene were found to contribute to 
attenuated virulence and long term colonization abilities in clinical isolates belonging to other successful lineages 
such as contemporary CC30 and USA300 (ST8) isolates24,25. Whether the phenotypic AgrC variation described 
the 24 h skin tissue model infection. The data represent the mean values ± s.d. from three independent infections (n = 3). 
(d) Relative mRNA expression of indicated genes encoding for surface-attached proteins during the 24 h skin tissue 
model infection. The data represent the mean values ± s.d. from three independent infections (n = 3). (e) IL-1β , (f) TNF, 
(g) CXCL8, and (h) IL-6 relative mRNA expression compared to unstimulated model (black line; left panel) and 
protein (right panel) released in response to infection from skin tissue model supernatants. The data represent the 
mean values ± s.d. (n≥ 3). The statistical significance between wild-type and respective mutant strains was determined 
using two-tailed Mann-Whitney U-test (* p < 0.05; * * p < 0.01; * * * p < 0.001).
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here represents a mechanism underlying the success of ST22 as a globally disseminating MRSA clone seems plau-
sible but remains to be proven. Whether this phenotypic switch represents a mechanism for which new variants 
might emerge, such that they provide a reservoir for dissemination and become difficult to eradicate, thereby con-
tributing to the ongoing persistence of ST22 and other successful MRSA clones, warrants further studies.
Methods
Ethics statement. Blood samples from healthy volunteers or buffy coats of blood provided by the blood bank 
at the Karolinska University Hospital were used. The buffy coats were provided anonymously. In case of healthy 
volunteers, donors were individuals well acquainted with the research conducted; thus, verbal informed consent 
was deemed sufficient. The ethical research committee at Huddinge University Hospital (Forskningskommitté 
Syd) approved the study including this consent procedure.
All animal experiments were carried out in accordance with the recommendations in the Guide for the Care 
and Use of Laboratory Animals of the National Institutes of Health and with the prior approval of the Institutional 
Animal Care and Use Committee of the University of North Dakota, Grand Forks, ND 58202 (UND approval 
number 1310-01).
Figure 5. Bacterial intracellular localization and autophagy induction by strains with different AgrC 
variants. (a,b) Representative micrographs and quantitative analysis of LAMP1 and S. aureus co-localization 
in infected keratinocytes monolayers after 2 h of infection. (c,d) Representative micrographs and quantitative 
analysis of LAMP1 and S. aureus co-localization in infected skin tissue models after 24 h of infection.  
(e–g) Representative micrographs, quantitative analysis of MFI of LC3AB, and analysis of LC3AB and S. aureus 
co-localization in infected keratinocytes monolayers after 2 h of infection. (h–j) Representative micrographs, 
quantitative analysis of MFI of LC3AB, and analysis of LC3AB and S. aureus co-localization in infected skin 
tissue models after 24 h of infection. (k) The MIC of LL-37 towards the S. aureus were determined from two 
independent experiments performed in triplicates. (a–j) The data represent the mean values ± s.d. from three 
independent infections (n = 3). The statistical significance between wild-type and respective mutant strains was 
determined using two-tailed Mann-Whitney U-test (* p < 0.05; * * p < 0.01; * * * p < 0.001).
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All experiments were carried out in accordance with the approved guidelines.
Bacterial strains, eukaryotic cells and culture conditions. S. aureus clinical isolates used in this study 
are summarized in Supplementary Table 1. The strains were cultured overnight at 37 in casein hydrolysate and 
yeast extract (CCY) medium. Cell-free supernatants were prepared through centrifugation at 3350 × g followed 
by filtration (0.25 μ m).
The human keratinocyte cells (N/TERT-1; a gift from Dr. J. Rheinwald and the Cell Culture Core of the 
Harvard Skin Disease Research Centre, Boston, MA; Immortalized cells from genetically normal individuals; 
Phenotypical analysis was done by the reference lab mentioned above) were maintained in EpiLife medium 
(Invitrogen). Normal human dermal fibroblasts (primary cell lines cultured from genetically normal individuals) 
were cultured in DMEM (Invitrogen) supplemented with 10% (v/v) fetal bovine serum (FBS; Invitrogen). Both 
were cultured at 37 °C under a 5% CO2 atmosphere. Mycoplasma free cells were cultured under antibiotic free 
conditions. The cells were tested every month (ATCC Universal Mycoplasma detection kit; Cat No: 30-1012K).
Human neutrophils and PBMCs were isolated from peripheral blood collected from healthy donors by 
Polymorphprep or Ficoll-Hypaque gradient centrifugation (Axis-Shields), respectively. Both cell types were cul-
tured in RPMI 1640 media (HyClone) supplemented with 5% (v/v) FCS.
Mutagenesis and production of recombinant AgrC proteins. Recombinant wild-type AgrC 
protein was expressed and purified as previously detailed38. The AgrCY223C protein was obtained by site-directed 
mutagenesis of the wild-type AgrC construct using the primers Y223C_F(5′ TGTACATTGAAGATTGAAGC 
TATCAACAACGAAATG3′)/Y223C R(5′ TTCATAATAGGTTTCAATTTCTTCTTGATTACGTTTATA 
TTTC-3′ ). The resulting site directed mutated plasmid was verified by sequencing. Recombinant AgrCY223C pro-
tein was expressed in Escherichia coli BL21 DE3* cells and was purified by Ni-NTA metal affinity chromatography 
as detailed38.
Bio-layer Interferometry. The interaction kinetics of AgrCY223C with AgrAFL (ligand) was analyzed by 
bio-layer interferometry. AgrAFL was immobilized on a Amine reactive 2nd generation (AR2G) tips (Fortebio, 
Inc). Two reference tips, one with the ligand and the other with highest concentration of analyte were used. These 
experiments were performed in a buffer containing 20 mM HEPES, pH 7.6, 200 mM KCl, 2% glycerol. Both 
AgrCY223C and AgrCwt were incubated separately with 5 μ M of DTT and H2O2 respectively in these experiments. 
The binding kinetics were analyzed using the Octet Data Analysis Software v 8.0.
Figure 6. In vivo infections with S. aureus strains harboring tyrosine at position 223 of AgrC result in 
severe tissue damage. (a) Bacterial loads and dissemination from indicated mice strains infected with indicated 
S. aureus strains. (b) Lesion sizes of indicated mice strains infected with indicated S. aureus strains at days 
3 and 6 post infection. (c) Representative images of lesion sizes at day 6 post infection. In total, three mice 
strains (C57BL/6J [red], DBA/2J [blue], and BALB/c [black]) were used. From each group three mice were 
infected with indicated S. aureus strain and the infection was monitored over a period of six days. Each symbol 
represents one mouse and horizontal lines represent the median value. The statistical significance between wild-
type and respective mutant strains was determined using two-tailed Mann-Whitney U-test (* * * p < 0.001).
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Whole genome sequencing and analyses. Whole genome sequencing of S. aureus M37 and PUNE08 
isolates was performed using massively parallel high throughput sequencer Illumina Hiseq-1000. The raw-reads 
for both isolates were filtered for quality and more than, 8 million reads were obtained with at-least 100X coverage 
for the 2.8 Mb S. aureus genome. The raw reads were assembled into contigs using VELVET version 1.2547 and 
gene predictions were made using GLIMMER 3.0248. The protein sequences were derived from the above gene 
sequences using EMBOSS transeq49 the relative arrangement of the contigs was determined by BLASTP and 
TBLASTN50. The sequences are deposited in the DNA data bank of Japan (DDBJ) and the accession numbers are 
M37 wt: BCLL01000001-BCLL01000060 and PUNE08 wt: BCLM01000001-BCLM01000056.
In total, 14 genes (spa, hla, hld, hlg, pvl, psmα and β, sarA, rot, sigB, agrA, B, C and D) associated with virulence 
or regulation of virulence factor expression were analyzed. After the BLASTP/BLASTN prediction of the genes, 
1 kb upstream/downstream region sequences (to include the promoter region also) were extracted from the con-
tig sequences using PERL script. The extracted sequences were aligned using online CLUSTAL W tool.
Targeted agrC sequence analysis. For agrC gene specific sequencing, DNA from ST22 S. aureus strains 
was isolated using DNA Blood and Tissue Kit (Qiagen) according to manufacturer’s instructions and the agrC 
gene was (i) amplified by using primers presented in Supplemental Table 3 and (ii) the sequencing was performed 
by SourceBioscience (Germany). The extracted sequences were aligned using online CLUSTAL W tool.
Construction of the mutant strains by allelic exchange of agrC in S. aureus strains. Plasmids were 
constructed to swap the PUNE08 agrCY223 (EryR) and M37 agrCC223 (EryS) into the opposing backgrounds. From 
genomic DNA of either PUNE08 or M37, a 1.1 kb amplicon centered on the agrC single nucleotide 
polymorphism were amplified with primers IM406 (5′ -CCTCACTAAAGGGAACAAAAGCTGGGTACC 
C T T G AT TAT T T T T T C AT C ATAG TA AT T T C G 3 ′  ) / I M 4 0 7 ( C G AC TC AC TATAG G G C G A AT 
TGGAGCTCTTTTAAAGTTGATAGACCTAAACCACG). The gel-purified amplicons were recombined into 
pIMAY-Z51 by SLiCE52 and transformed into E. coli strain IM08B51. The inserts from positive clones were verified 
by Sanger sequencing. The method of Monk et al.51 was followed for the transformation and allelic exchange with 
M37 and PUNE08. Putative allele swaps were initially screened for the gain (M37) or loss (PUNE08) of hemolysis 
on sheep blood agar with subsequent sequencing of the agrC gene to validate the introduction of the SNP. This 
yielded PUNE08 agrC-Y223C and M37 agrC-C223Y with both maintaining their parental erythromycin resist-
ance/sensitivity profiles.
Infection and supernatant stimulations of human cells. Adherence to, internalization into, and exit 
from eukaryotic cells were quantified using the antibiotic protection assay53. Briefly, 24-well plates were inocu-
lated with 2 × 105 N/TERT-1 cells/well in EpiLife without antibiotics. The cells were allowed to grow to conflu-
ence. For the assay, the cells were washed and infected with S. aureus strains at a multiplicity of infection (MOI) 
of 1:10. Two hours after infection, the viable counts of S. aureus (colony-forming units, CFU) released from lysed 
cells were determined by plating on blood agar. For the assessment of bacterial internalization, 2 h after infection, 
the cells were washed with PBS and incubated with media supplemented with lysostaphin (20 μ g ml−1) and gen-
tamicin (120 μ g ml−1) for an additional 2 h. Subsequently, the cells were washed and lysed, and the CFU counts 
were determined as described above.
Cells were stimulated with bacterial supernatants (1:50 diluted). Keratinocytes (1.5 × 105) and PBMCs 
(8 × 105) were stimulated for 24 h and neutrophils (5 × 105) for 2 h after which supernatants were collected. 
CCY-stimulated and Triton X-lysed cells were used as negative and positive controls, resp. Cytotoxicity were 
determined by measurement of the LDH activity via CytoTox 96 Non-Radioactive Cytotoxicity Assay Kit 
(Promega) according to manufacturer’s guidelines.
For assessment of proliferation, PBMCs (2.5 × 105 cells/well) were seeded in 96-well plates and stimulated 
for 72 h with varying dilutions of bacterial supernatants (1:10–1:1000). The cells were pulsed with 1 μ Ci of 
3H-thymidine (GE Healthcare) for additional 6 h of incubation and the uptake of the 3H-thymidine was measured.
SDS-PAGE and Immuno-detection of TNF-R1 and Caspase 1. 2 × 105 N/TERT-1 cells were infected 
at a MOI of 10 for 2 or 4 h and lysed with NBP-40/TritonX buffer. Samples were normalized to equal amounts 
of protein and boiled in sample buffer (Invitrogen). As molecular mass marker, pre-stained protein standards 
(Bio-Rad) were used. The samples were separated by 12% SDS-PAGE and transferred to a PVDF membrane. The 
membranes were blocked with 3% BSA prior to antibody incubations. Antibody incubations were performed 
according to manufacturer´s guidelines. Antibodies used in this study: TNF-R1 (C25C1), caspase-1 antibody 
(Cat No: 2225), cleaved caspase-1 (D57A2), β -Actin (D6A8) (all Cell Signaling Technology,) and secondary 
anti-rabbit IgG horseradish peroxidase linked Fab fragment (GE Healthcare).
Detection of caspase-1 activity. The active caspase 1 was detected using FAM-YVAD-FMK staining kit 
(Immunochemistry Technologies). Keratinocytes were infected with S. aureus strains at MOI 1:10 for two hours 
and further staining experiments were performed according to the manufacturer’s protocol. Active caspase 1 was 
visualized using Nikon A1 confocal microscope (Nikon Instruments).
3D organotypic skin-model and infection. The models were generated following a previously published 
protocol54. The skin models were incubated for up to 7 d at 37 °C under a 5% CO2 atmosphere, and the culture 
medium was replaced every second day in the outer chamber. After air exposure the models were infected with 
0.25 × 106 bacteria for 24 h.
Histological analysis of tissue biopsies. For cryosectioning, skin tissue models were treated with 2.0 M 
sucrose for 1 h before embedding in optimum cutting temperature compound (Sakura Finetek) followed by 
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freezing in liquid nitrogen and stored at − 80 °C. 8 μ m cryosections were obtained using a MICROM cryostat HM 
560 MV (Carl Zeiss) and fixed in 2% freshly prepared formaldehyde in PBS for 15 min at room temperature or in 
ice-cold acetone for 2 min at − 20 °C.
For histological analysis, the sections were stained for 15 sec in Mayer’s haematoxylin and counterstained for 
2 min in eosin. Histological severity scoring was performed in a double blinded manner using the following crite-
ria, 0 unaffected tissue, 0.5–1 mild injury with minor epithelial loosening, 1.5–2 moderate injury with some epi-
thelial disruption, 2.5–3 severe injury with continuous epithelial disruption and some detachment, 4 = extensive 
injury, massive epithelial disruption and detachment. Bacteria were identified via conventional Gram staining.
Immunostainings and Confocal Microscopy. Infected cells and skin tissue sections were fixed in 
2% formaldehyde in PBS. Immunofluorescence staining was performed using following primary antibod-
ies: Rabbit anti-human LAMP1 (abcam; Cat No: ab24170), Mouse anti-Staphylococcus aureus (704)(abcam), 
Rabbit anti-human LC3A/B (D3U4C) (cell signalling technologies). Specific staining was detected by Alexa 
488-conjugated donkey anti-mouse IgG, Alexa 546-conjugated donkey anti-rabbit IgG (3.3 μ g/ml) and DNA 
were stained with DAPI (all from Molecular Probes). The staining’s were visualized using a Nikon A1R confocal 
microscope (Nikon Instruments). Colocalization between S. aureus and LC3AB and LAMP, respectively, was 
analyzed using the image analysis software CellProfiler (version 2.1.1). In short, images were threshold, smoothed 
and segmented based on the respective channels for S. aureus and LC3AB or LAMP. Based on the segmented area, 
the fraction of S. aureus inside the LC3AB or LAMP positive areas (% colocalization) was calculated. The mean 
fluorescence intensity (MFI) in 10–15 fields/tissue sections was determined using the image analysis software 
CellProfiler (version 2.1.1).
RNA Preparation and Quantitative Reverse Transcription PCR Analysis (qRT-PCR). Bacterial 
RNA was isolated using FastRNA Blue (MP Biomedicals) and eukaryotic RNA was isolated using RiboPure 
RNA purification Kit (Ambion) according to manufacturer´s guidelines. cDNA synthesis was performed using 
the Superscript first-strand synthesis system for RT-PCR (Invitrogen). Primer sets used are summarized in 
Supplementary Table 3. The real-time PCR amplification was performed with SYBR GreenER Kit (Invitrogen) 
using an ABI Prism 7500 sequence detection system (Applied Biosystems). The levels of gyrA or β -actin transcrip-
tion were used for normalization.
Antimicrobial Susceptibility Testing. The minimum inhibitory concentration (MIC) of LL-37 against 
ST22 S. aureus strains was determined using bacteria from the stationary phase. The experiment was performed 
by adding LL-37 in different concentrations diluted in 0.1% TFA as described previously55. The numbers of CFU 
were analyzed and MIC was defined as the lowest concentration of LL-37 that significantly reduced the bacterial 
CFU in relation to peptide-free control cultures56.
TNF, IL-1β, IL-6, and CXCL8 ELISAs. The levels of TNF, IL-1β , IL-6, and CXCL8 in supernatants of 
infected skin tissue models were measured using human TNF, IL-1β , IL-6, and CXCL8 Quantikine ELISA (R&D 
Systems) according to manufacturer´s guidelines.
Subcutaneous infection of mice. One day prior to infection the hair was removed from the dorsal side 
of the mouse with Nair™ hair removal lotion (Church & Dwight Co., Inc). 12 weeks old mice (n = 3) of different 
genetic background (C57Bl/6J – 7M/7F; DBA/2J – 8M/6F; BALB/C – 7M/7F) were infected subcutaneously with 
1 × 108 CFU/100 μ l PBS of PUNE08 wt, PUNE08 agrC-Y223C, M37 wt, and M37 agrC-C223Y each (in total 
9 mice infected/bacterial strain). Control animals (n = 6, 2 mice/genetic background) were given injections of 
sterile PBS alone. Animals were randomly assigned to cages so that each group had 9 mice (3 Balb/c, 3 C57B/6J 
and 3 DBA/2J). Controls had 2 mice of each. No specific randomization method was used for allocation. The 
investigator was not blinded to group allocation. After infection, each mouse was housed in an individual cage. 
Animals were observed twice a day for the next six days for mortality, and lesions size. No animals were excluded 
from analysis. On day 6 lesion size was measured, photographed and the mice sacrificed using approved methods.
Statistical analysis. No statistical methods were used to predetermine sample size. Data are presented 
as mean ± s.d. for the indicated number of experiments. The data were analyzed with use of the Graphpad 
Prism v.5 software (GraphPad, San Diego, CA). Due to small sample size no normality test was performed and 
non-parametric two-tailed Mann-Whitney U-test was applied for all comparisons between PUNE08 and M37 or 
between wild-type strains and their respective mutant, p values less than 0.05 were considered significant.
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